← Back to work
Works citing this work
2 works
Work: May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?
Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)
E. I. Tarlovskaya, A. G. Arutyunov, А. О. Конради +97
ABI